These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23806096)

  • 1. Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes.
    Ceriello A; Novials A; Ortega E; Canivell S; Pujadas G; La Sala L; Bucciarelli L; Rondinelli M; Genovese S
    Cardiovasc Diabetol; 2013 Jun; 12():97. PubMed ID: 23806096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes.
    Ceriello A; Novials A; Ortega E; Canivell S; La Sala L; Pujadas G; Bucciarelli L; Rondinelli M; Genovese S
    Diabetes Care; 2013 Dec; 36(12):4104-8. PubMed ID: 24130351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes.
    Ceriello A; Novials A; Ortega E; La Sala L; Pujadas G; Testa R; Bonfigli AR; Esposito K; Giugliano D
    Diabetes; 2012 Nov; 61(11):2993-7. PubMed ID: 22891214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
    Ceriello A; Novials A; Ortega E; Canivell S; La Sala L; Pujadas G; Esposito K; Giugliano D; Genovese S
    Diabetes Care; 2013 Aug; 36(8):2346-50. PubMed ID: 23564922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes.
    Ceriello A; Novials A; Canivell S; La Sala L; Pujadas G; Esposito K; Testa R; Bucciarelli L; Rondinelli M; Genovese S
    Diabetes Care; 2014 Jul; 37(7):1938-43. PubMed ID: 24667461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls.
    Ceriello A; Novials A; Ortega E; Pujadas G; La Sala L; Testa R; Bonfigli AR; Genovese S
    Nutr Metab Cardiovasc Dis; 2014 Feb; 24(2):116-23. PubMed ID: 24094827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes.
    Ceriello A; De Nigris V; Pujadas G; La Sala L; Bonfigli AR; Testa R; Uccellatore A; Genovese S
    Diabetes Res Clin Pract; 2016 Apr; 114():64-8. PubMed ID: 27103371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes.
    Ceriello A; Esposito K; Testa R; Bonfigli AR; Marra M; Giugliano D
    Diabetes Care; 2011 Mar; 34(3):697-702. PubMed ID: 21273492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report.
    Ceriello A; Esposito K; La Sala L; Pujadas G; De Nigris V; Testa R; Bucciarelli L; Rondinelli M; Genovese S
    Cardiovasc Diabetol; 2014 Nov; 13():140. PubMed ID: 25407792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes.
    Ceriello A; Piconi L; Esposito K; Giugliano D
    Diabetes Care; 2007 Jul; 30(7):1694-8. PubMed ID: 17456844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics.
    Ceriello A; Esposito K; Ihnat M; Thorpe J; Giugliano D
    Diabet Med; 2010 Aug; 27(8):911-7. PubMed ID: 20653749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
    McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
    Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
    Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
    Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
    Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
    J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.
    Ceriello A; Esposito K; Ihnat M; Thorpe J; Giugliano D
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2751-6. PubMed ID: 19491221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.
    Pleiner J; Schaller G; Mittermayer F; Marsik C; MacAllister RJ; Kapiotis S; Ziegler S; Ferlitsch A; Wolzt M
    Atherosclerosis; 2008 Mar; 197(1):383-91. PubMed ID: 17645881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment with GLP-1 after severe trauma preserves renal function in obese Zucker rats.
    Xiang L; Thompson MS; Clemmer JS; Mittwede PN; Khan T; Hester RL
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R621-R627. PubMed ID: 30811247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.